Ant Group Brings Alipay+ to the Philippines with Three New Mobile Wallets, AlipayHK, Kakao Pay and Touch ‘n Go eWallet
Ant Group, the operator of Alipay+, the global cross-border digital payments and marketing solution, today announced that a total of four mobile wallets are now accepted in the Philippines. These include AlipayHK (Hong Kong SAR), Kakao Pay (South Korea), Touch ‘n Go eWallet (Malaysia) and Alipay (Chinese mainland), which has been accepted by Filipino merchants since 2017. This enables travellers from these regions to enjoy a cashless experience, using just their home mobile wallets to make payment, improving the travel experience as digital payment options like mobile wallets become the norm for day-to-day transactions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230904840228/en/
Mactan-Cebu International Airport, which saw 219% increase in passengers in the 1H of 2023, have integrated Alipay+ across 90% of its merchants (Photo: Business Wire)
The acceptance of three new mobile wallets, via Alipay+, comes as travellers return to the Philippines. According to the Department of Tourism (DOT), more than 3 million tourists have visited the Philippines from January 1 to July 19, 2023, reflecting continued robust recovery. The DOT also shared that inbound tourism receipts from January 1 to June 30, 2023, are more than 500% higher than the same period last year1. South Koreans top the list of international visitors to the Philippines, while Malaysia ranks in the top 102.
Alipay+ is currently accepted by merchants in Manila and Cebu, the top two most visited cities in the Philippines pre-pandemic in 20193. In the first half of 2023, Mactan-Cebu International Airport saw a 219% increase in passengers compared to the same period last year. In order to cater to the new expectations of digital-first travellers, the airport has integrated Alipay+ across 90% of its merchants, ensuring that tourists can enjoy a digitally-enhanced cashless experience from the moment they arrive in Cebu.
Athanasios Titonis, Aboitiz InfraCapital Chief Executive Officer assigned to MCIA, said: “At MCIA, we have always placed utmost importance on providing convenience and ease of travel through seamless processes and world-class services and amenities. The integration of Alipay+ gives our passengers that exceptional convenience and more payment options when they travel through MCIA.”
Mactan-Cebu International Airport (MCIA) is the second largest airport in the Philippines with over 11 million passengers annually, making it the second busiest airport in the country. With its strategic location and world-class facilities, MCIA aims to establish itself as the main tourism gateway of the country with exceptional travel experience, connecting the world to the Philippines. To date, MCIA is the first and only airport in the Philippines to receive the Airport Customer Experience (ACX) accreditation from the Airports Council International.
Commenting on this new development, Dr. Cherry Huang, General Manager of Alipay+ Offline Merchant Services at Ant Group, said: “Philippines and its many islands, such as Cebu, have long been a favourite destination for Asian travellers and we look forward to working with our local partners to enhance their travel experience. We believe that digital adoption and solutions will shape travellers’ expectations, particularly in the way the engage travel-related businesses, from airports and hospitality to F&B and retail stores. Our focus now is to work with more partners to onboard more merchants with Alipay+ across the Philippines, particularly local small businesses, and promote digital travel and travel recovery.”
Introduced by Ant Group in 2020, Alipay+ aims to enable local businesses, especially small and medium-sized businesses, to process a wide range of mobile payment methods and reach more than 1.4 billion regional and global consumers, through one-time integration and simple technical adaption. In addition to the Philippines, Alipay+ is also widely accepted in destinations including the Chinese mainland, Macao SAR, Singapore, Thailand, Japan and South Korea among others.
About Mactan-Cebu International Airport
Mactan-Cebu International Airport (MCIA) is the second largest airport in the Philippines. It serves over 11 million passengers annually, making it the second busiest airline hub in the country. MCIA is operated by a Filipino-led private consortium between Aboitiz InfraCapital (AIC), GMR Group of India, and Megawide Construction Corporation (MCC), under a concession agreement with the Philippine Government. With its strategic location and world-class facilities, MCIA aims to establish itself as the main tourism gateway of the country with exceptional travel experience, connecting the world to the Philippines. MCIA is accredited for the Airport Customer Experience (ACX) and the Airport Health Accreditation (AHA) by the Airports Council International.
About Ant Group
Ant Group aims to create the infrastructure and platform to support the digital transformation of the service industry. It strives to enable all consumers and small and micro businesses to have equal access to financial and other services that are inclusive, green and sustainable.
Ant Group is the owner and operator of Alipay, the leading digital payment platform in China serving hundreds of millions of users, and connecting them with merchants and partner financial institutions that offer inclusive financial services and digital daily life services such as food delivery, transport, entertainment, and healthcare.
Ant Group has further introduced Alipay+, which provides global cross-border mobile payments and marketing solutions that connect merchant partners, especially small and medium-sized businesses, with mobile payments and other payment methods, for them to better serve their users and customers from all over the world.
Alipay+ offers unified global mobile payment and marketing solutions that connect merchants with multiple e-wallets and payment methods from different countries and regions by collaborating with global partners. Consumers can conveniently use their preferred local payment methods while transacting seamlessly in a different market and be able to enjoy marketing offers by the merchants through Alipay+. Alipay+ is developed by Ant Group, the owner and operator of Alipay, one of the world’s leading digital open platforms.
1 Manila Bulletin (19 July 2023): PH int’l tourists breach 3M mark, revenues hit P212B
2 Department of Tourism: Tourism demand statistics 2023
3 Department of Tourism: Visitor arrivals: January – December 2019
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Altasciences Chosen by Virpax to Support the Development of a New Drug to Prevent Spread of Flu-like Viruses21.9.2023 17:00:00 EEST | Press release
Altasciences is pleased to have been chosen by Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) (“Virpax”), a company specializing in developing non-addictive products for pain management, PTSD, central nervous system (CNS) disorders, and viral barrier indications, to conduct preclinical studies in support of their development of quaternary ammonium palmitoyl glycol chitosan (GCPQ, under the trade name of AnQlar™). AnQlar is a nanoparticle intended to help prevent the spread of negatively charged viruses such as COVID-19 and influenza via intranasal spray, and has shown to inhibit the ability of the virus to replicate at non-toxic concentrations. In development since 2022, the project has so far seen the completion of safety assessment utilizing intranasal administration at Altasciences’ preclinical site in Columbia, MO. A cardiovascular study was also completed at Altasciences’ preclinical facility in Scranton, PA. Bioanalytical sample analysis for the GLP studies is currently ongoing. “We
Nitek: End of the Road for Copycats21.9.2023 16:00:00 EEST | Press release
Nitek, Inc. (“Nitek”), a pioneering American company in UV LEDs, has announced that it filed a patent infringement lawsuit against Photon Wave Co., Ltd. (“Photon Wave”), a Korean UV LED manufacturer in the Eastern District of Texas. In the complaint, Nitek asserts that LED products of ams OSRAM, a German LED company, use Photon Wave’s infringing LEDs. Nitek also contends that Photon Wave has failed to cease selling infringing products, even after getting continuous warning notices of the patent infringement, and therefore Nitek is not only seeking a permanent injunction against the sales of infringing products but also pursuing 3 times damages for willful patent infringement. Nitek has previously successfully won its patent lawsuit against another international LED maker, and continues its enforcement against other infringers. Sensor Electronic Technology, Inc. (“SETi”), an affiliate of Nitek, has also obtained a permanent injunction for patent infringement against Bolb, Inc., a UV LED
Boomi Launches World Tour, Bringing Together Visionary Leaders and Industry Experts to Prepare Businesses for the AI Revolution21.9.2023 16:00:00 EEST | Press release
Boomi™, the intelligent connectivity and automation leader, today announced the Boomi World Tour, a premiere series of exclusive, in-person events bringing together Boomi customers, prospects, and partners to hear directly from Boomi leadership, industry experts, and visionaries on how organizations can leave complexity behind and synchronize everything, everywhere, with AI-driven integration and automation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230921479137/en/ Boomi Launches World Tour, Bringing Together Visionary Leaders and Industry Experts to Prepare Businesses for the AI Revolution (Graphic: Business Wire) The Boomi World Tour is a series of 10 events over eight weeks, including three Partner Summits designed especially for Boomi partners, global systems integrators, and OEMs. The tour kicks off in Menlo Park, CA, October 3-4, 2023, where attendees will have opportunities to connect and learn throughout the tw
Hologic and Bayer Announce International Partnership to Deliver Comprehensive Contrast-Enhanced Mammography Package to Breast Imaging Facilities21.9.2023 15:30:00 EEST | Press release
Hologic Inc. (Nasdaq: HOLX) and Bayer today announced an international partnership to deliver contrast-enhanced mammography (CEM) solutions to improve the detection of breast cancer for women in multiple countries across the European, Canadian and Asia Pacific regions. CEM is a highly sensitive and relatively low-cost breast imaging modality that combines digital mammography with the administration of a contrast agent to support breast cancer diagnosis and guide treatment decisions.1 The partnership brings together the companies’ leading technologies (Hologic mammography gantries and Bayer CEM-approved injection systems) to enable the administration of contrast media during a mammography examination. With the new agreement, Bayer and Hologic aim to optimally support radiologists and their teams’ needs by providing a comprehensive product package along with the hands-on training needed to effectively implement CEM into their facility’s workflow. “Over the past several years, we’ve seen
ReNAgade Therapeutics Named to the 2023 Endpoints 1121.9.2023 15:00:00 EEST | Press release
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced that it has been named as one of the Endpoints 11 companies of 2023, awarded by Endpoints News editor John Carroll to the most promising private biotechnology companies in the industry. “To be included as one of the Endpoints 11 top private biotech companies is not only a great honor for our young company, but also recognition from the industry of what we’ve already accomplished in the past 18 months toward our aim of overcoming the current limitations of RNA medicines,” said Amit D. Munshi, Chief Executive Officer of ReNAgade. “The Company has continued to grow since our $300 million Series A financing round, building on our world-class, multidisciplinary team that is dedicated to innovating delivery technology and bringing an array of genomic medicine tools under one roof. We look forward to expanding the reach of RNA medicine beyond what was previously thought possible, beginning wi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom